Astellas Pharma acquires Iveric Bio for $5.9 billion – Kommersant
Japanese pharmaceutical company Astellas agreed with the American Iveric Bio to buy all of its shares at a price of...
Japanese pharmaceutical company Astellas agreed with the American Iveric Bio to buy all of its shares at a price of...